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Triglyceride homeostasis is a key process of normal develop-
ment and is essential for the maintenance of energy metabo-
lism. Dysregulation of this process leads to metabolic disor-
ders such as obesity and hyperlipidemia. Here, we report a 
novel function of the Drosophila flightless-I (fliI) gene in lipid 
metabolism. Drosophila fliI mutants were resistant to starva-
tion and showed increased levels of triglycerides in the fat 
body and intestine, whereas fliI overexpression decreased 
triglyceride levels. These flies suffered from metabolic stress 
indicated by increased levels of trehalose in hemolymph and 
enhanced phosphorylation of eukaryotic initiation factor 2 
alpha (eIF2α). Moreover, upregulation of triglycerides via a 
knockdown of fliI was reversed by a knockdown of desat1 in 
the fat body of flies. These results indicate that fliI suppresses 
the expression of desat1, thereby inhibiting the development 
of obesity; fliI may, thus, serve as a novel therapeutic target in 
obesity and metabolic diseases. 
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INTRODUCTION 
 
Flightless-I (fliI) is an actin-binding protein and performs im-
portant functions in early embryogenesis in Drosophila. Se-
vere defects in the fliI locus lead to impaired cellularization 
and gastrulation of Drosophila embryos (Straub et al., 1996), 
and mild mutations in the fliI gene cause defects in the de-
velopment of flight muscles and the loss of the ability to fly 
(Campbell et al., 1993; Deak et al., 1982; Miklos and De  
Couet, 1990). The fliI protein in Drosophila is highly con-
served as compared to mice and humans. This protein con-
tains a leucine-rich repeat (LRR) at the N terminus and a 
gelsolin-like repeat at the C terminus (Campbell et al., 1993). 
The LRR region is known to be involved in protein–protein or 
protein–lipid interactions (Kajava et al., 1995; Kobe and 
Deisenhofer, 1995) that are responsible for Ras signal trans-
duction (Claudianos and Campbell, 1995; Goshima et al., 
1999). The gelsolin-like repeat interacts with actin and actin-
binding proteins (Campbell et al., 1993; Claudianos and 
Campbell, 1995; Davy et al., 2001). PI3 kinase and small 
GTPase are involved in fliI-mediated cytoskeletal regulation. 
In addition, fliI negatively regulates wound repair through its 
effect on hemidesmosome formation and integrin-mediated 
cellular adhesion and migration (Kopecki et al., 2009). On 
the other hand, the fliI protein functions as a transcriptional 
coregulator by interacting with hormone-activated nuclear 
receptors, such as estrogen receptor (ER), thyroid receptor 
(TR), and other coregulators, including glucocorticoid recep-
tor–interacting protein (GRIP), coactivator-associated argi-
nine methyltransferase (CARM1), and BAF53 (Choi et al., 
2015; Lee and Stallcup, 2006; Lee et al., 2004; Wu et al., 
2013). Moreover, FliI inhibits β-catenin–mediated transcrip-
tion by disrupting formation of the FLII leucine-rich repeat–
associated protein 1 (FLAP1)–p300–β-catenin complex (Lee 
and Stallcup, 2006) and negatively regulates carbohydrate 
response element–binding protein (ChREBP) in HCT116 cells 
(Wu et al., 2013). 
The maintenance of fat content is central to normal devel-
opment and essential for energy metabolism (Ducharme and 
Bickel, 2008). Drosophila fat is mainly stored as triglycerides  
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in the fat body, which is equivalent to mammalian adipose 
tissue and liver (Arrese et al., 2001; Canavoso et al., 2001). 
The storage and mobilization of fat are dynamically con-
trolled by lipogenesis and lipolysis cycles in response to nutri-
ent levels in the body. When the organism has enough nu-
trients for survival, dietary fat is hydrolyzed to fatty acids by 
gastric lipase, which are then absorbed in the intestine. The 
absorbed fatty acids are utilized for the resynthesis of triglyc-
erides in the fat body of Drosophila or in the adipose tissue 
of mammals. Nonetheless, nutrient deprivation triggers a 
release of fatty acids by specific lipid droplet–associated li-
pases to supply energy through mitochondrial fatty acid β-
oxidation (Arrese et al., 2001; Canavoso et al., 2001). 
Dysregulation of fat metabolism can lead to metabolic aber-
rations, eventually causing metabolic disorders, such as obe-
sity, type 2 diabetes, and cardiovascular disease. 
As described above, fliI primarily participates in cytoskeletal 
regulation and cell migration as a member of the actin-
remodeling protein family (Davy et al., 2000; 2001). In addi-
tion to regulating cytoskeletal function, a recent study has 
revealed that fliI regulates gene transcription by interacting 
with nuclear receptors, such as peroxisome proliferator-
activated receptor γ (PPARγ), by modulating the expression 
of lipogenic enzymes (Choi et al., 2015). These findings pro-
pelled us to determine whether fliI plays a role in lipid me-
tabolism. Here, we report that Drosophila fliI mutants are 
resistant to starvation and have larger amounts of triglycer-
ides in the fat body and intestine. FliI mutants showed high 
mRNA expression of desaturase 1 (desat1), whose preferred 
substrate is stearoyl-CoA. Furthermore, a fat-body–specific 
knockdown of fliI increased the level of triglycerides, and this 
change was reversed by a desat1 knockdown in the fat body. 
Conversely, overexpression of fliI significantly reduced the 
amount of triglycerides and mRNA expression of desat1; this 
result was further validated in mammalian cells. Mammalian 
fliI significantly reduced transcript levels of SCD1, SCD2, and 
SCD4 in 3T3-L1 preadipocytes, the mammalian homologs of 
desat1. Taken together, these results support the involve-
ment of fliI in lipid metabolism and suggest that fliI may be a 
novel therapeutic target in obesity and metabolic diseases. 
 
MATERIALS AND METHODS 
 
Plasmids and fly strains 
The coding sequence of flightless-1 was obtained by RT-PCR 
from yw larvae. The HA-tag was added to the C termini of 
these coding sequences, and they were subcloned into 
pUAST (Brand and Perrimon, 1993). All Drosophila stocks 
were raised on a standard cornmeal medium containing 
4.94% molasses, 3.8% cornmeal, 1.6% yeast, and 1.2% 
agar at 25℃. Genes were expressed in Drosophila by means 
of the standard Gal4/UAS system. Flies w1118 (stock number 
5905), fliI3 (stock number 4730), fliI14/FM6 (stock number 
7481), and P106 (Roman et al., 2001) (stock number 8151) 
were obtained from the Bloomington Stock Center. Flies 
UAS-fliI RNAi (stock number 39528) and UAS-desat1 RNAi 
(stock number 104350) were obtained from the Vienna 
Drosophila Resource Center. Alleles fliI3 (de Couet et al., 
1995) and fliI14 (Perrimon et al., 1989) were described previ-
ously. To implement RNAi, 100 μl of a 5 mg/ml solution of 
RU486 (cat. # M4086, Sigma) or vehicle (80% ethanol) was 
added on top of food in a food vial and dried overnight be-
fore being fed to the flies. 
 
Triglyceride quantification 
This procedure was carried out using the Triglyceride Rea-
gent (Thermo Electron Corp., TR22421). A total of five to 
ten female flies were homogenized in 200 μl of PBST (PBS 
with 0.1% Tween 20), and triglyceride levels were measured 
as previously described (Birse et al., 2010). Triglyceride 
amounts were normalized to total protein levels. To measure 
triglyceride levels in the fat body and intestine, we dissected 
the flies in cold PBS and collected the fat body and intestine, 
being careful to avoid contamination with other tissues. The 
collected tissues were homogenized in PBST. 
 
Tissue staining 
For the staining of neutral lipids, dissected tissues were fixed 
with 4% formaldehyde in PBS for 20 min and washed in PBS 
with 0.1% Triton X-100 (PBST2). The tissues were then 
stained with PBST2 containing bodipy 493/503 (1:2 000; 
Life Technologies). For Nile red staining, whole flies were 
fixed in 4% paraformaldehyde in PBST2 for 3 h at room 
temperature. The flies were washed three times in PBS for 5 
min. Abdomens were carefully dissected in PBS. The dissect-
ed abdomens were incubated for 30 min in a Nile red stain-
ing solution (1 mg/ml in dimethyl sulfoxide, 1:1 000 in 
PBST2). The abdomens were washed three times in PBS for 
5 min and then mounted on a slide glass with 50% glycerol 
in PBS. 
 
The starvation assay 
Twenty female flies (7 days old) of each genotype were 
transferred to vials containing 1% agar in PBS. The flies were 
transferred to fresh food every 12 h and maintained at 25℃; 
deaths were recorded at those time points. 
 
Quantification of feeding 
Twenty female flies (7 days old) were starved for 24 h in vials 
containing 1% agar in PBS or maintained on standard fly food. 
Next, they were transferred to vials containing 1% agar, 5% 
sucrose, and 2.5% blue food dye (Erioglaucine Disodium Salt, 
Sigma, cat. #861146). After 15 min of feeding, 10 flies were 
immediately frozen, homogenized in 300 μl of PBS, and cen-
trifuged for 25 min at 13 200 rpm (Eppendorf Centrifuge 
5415R). The absorbance of the supernatant was measured at 
625 nm on a spectrophotometer (Tecan). 
 
Quantitative RT-PCR 
Total RNA from five female flies was isolated using the TRIzol 
Reagent (Invitrogen, USA), and 200 ng of RNA was tran-
scribed with the ReverTra Ace qPCR RT Kit (Toyobo Co., Ja-
pan). Quantitative PCR amplification was run for 40 cycles by 
means of the TOPreal qPCR 2X PreMIX (SYBR Green with 
high ROX) and a LightCycler® 480 Real-Time PCR System. 
Rp49 served as a reference for normalization. Relative quan-
tification of mRNA was performed by the comparative CT 
method. The primers are listed in Supplementary Table 1. 
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Cell culture 
3T3-L1 cells were acquired from ATCC (USA) and cultured in 
Dulbecco’s modified Eagle’s medium with 10% of fetal bo-
vine serum. Cells were transfected with an empty vector or a 
vector carrying murine FLII, and stable transfectants were 
generated by neomycin (G418) selection. Total RNA was 
extracted from confluent preadipocytes for quantitative RT-
PCR. 
 
Statistical analysis 
Each experiment was repeated at least three times, and the 
data are presented as mean ± SE. Significance testing was 
based on Student’s t test. 
 
Abbreviations 
coenzyme A (CoA), DNA-binding domain (DBD), leucine-
rich repeat (LRR), PBS with 0.1% Tween 20 (PBST), PBS with 
0.1% Triton X-100 (PBST2), RNA interference (RNAi) 
 
RESULTS 
 
Drosophila fliI mutants show increased lipid storage 
To assess the physiological role of fliI in lipid metabolism, we 
used already characterized fliI mutant alleles, fliI3 and fliI14. 
The FliI3 mutant allele contains a single-base change of Gly at 
amino acid position 602 to Ser in the gelsolin-like repeat and 
may fail to interact with another protein, possibly specific to 
an indirect flight muscle (de Couet et al., 1995). The FliI14 
allele is lethal during larval and pupal stages, indicating that 
the fliI protein is essential for survival of the organism into 
adulthood (Perrimon et al., 1989). We examined the 
amounts of triglycerides in a fliI3/14 mutant background; such 
flies did not show any developmental defects. As presented 
in Fig. 1A and Supplementary Fig. S1, whole-body triglycer-
ide concentrations progressively increased up to threefold by 
day 7 of adult life (after hatching) in fliI3/14 mutants, when 
compared to control fly strains: w1118 and Canton S. Because 
the major sites of fat storage in Drosophila are the fat body 
(Gutierrez et al., 2007) and midgut, we isolated the fat body 
and intestine and quantified triglycerides in those organs. 
We found larger amounts of triglycerides in fliI3/14 mutants’ 
fat body in comparison with the control flies’ fat body (Fig. 
1B). As in the fat body, the level of triglycerides was slightly 
but significantly higher in fliI3/14 mutants’ intestine (Fig. 1C). 
 
 
 
A                      B                   C 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1. Drosophila flightless-1 (fliI) mutants show elevated levels of triglycerides. (A–C) Quantitation of triglycerides in the whole body (A), 
fat body (B), and intestine (C) of flies with the indicated genotypes. The relative triglyceride amount was significantly higher in fliI3/14 
mutants compared to controls (w1118 flies). The triglyceride amounts were normalized to the total protein amounts in those tissues. (D–I) 
Bodipy and Nile red staining of the dissected fat body and midgut from 7-day-old adult flies. (D, G) Bodipy staining. Enlarged lipid drop-
lets are visible in the fat body of fliI3/14 mutants (G). (E, F, H, I) Nile red staining shows increased lipid droplet size in the fat body of a 
fliI3/14 mutant (H). Dissected adult midguts stained with Nile red reveal significantly increased lipid staining in fliI3/14 mutants (I, I’) com-
pared to controls (w1118; panels F, F’). Genotypes: w1118 (D–F) and fliI3/14 (G–I). The scale bars in (D, E, F’) represent 50, 20, and 100 μm, 
respectively. Data are presented as mean ± SE from at least three independent experiments. The P values were calculated by Student’s t 
test; *P < 0.05, **P < 0.01, and ***P < 0.001. 
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Given that the levels of triglycerides between the two con-
trol strains, w1118 and Canton S, were not significantly differ-
ent, hereafter, we used only strain w1118 as a control for fliI 
mutants. To confirm these results, we stained fat bodies with 
lipophilic dyes bodipy and Nile red. This tissue staining re-
vealed smaller lipid droplets in the fat body of control flies 
compared to fliI3/14 mutants (Figs. 1D and 1E); fliI3/14 mutants 
had lipid droplets of variable size, with mostly enlarged lipid 
droplets (Figs. 1G and 1H). Consistent with these results, 
staining of the intestine with Nile red uncovered accumula-
tion of lipid droplets in fliI3/14 mutants (Figs, 1I and 1I'). The 
fliI mutants are deficient in the ability to fly owing to myofi-
brillar abnormalities in flight muscles. Therefore, to rule out 
the possibility that the loss of the flight ability underlies the 
obese phenotype, we clipped the wings of the control flies 
and compared the concentrations of triglycerides between 
the groups. The clipping of wings in the control flies did not 
significantly change triglyceride content (Supplementary Fig. 
S2). Taken together, these results indicated that fliI plays a 
central role in lipid storage in Drosophila. 
 
FliI mutants exhibit the features of metabolic disorders 
To test whether the increased triglyceride amount in fliI3/14 
mutants is related to a metabolic disorder, we examined the 
glucose level and expression of a stress marker. The hemo-
lymph glucose levels were similar between the two groups 
(Fig. 2A). In contrast, fliI3/14 mutants showed elevated circu-
lating sugar in the form of trehalose (Figs. 2B and 2C), which 
prompts us to test the level of insulin production in fliI3/14 
mutants. Insulin signaling pathway in Drosophila regulates 
growth, metabolic homeostasis, stress responses, reproduc-
tion, and lifespan (Brogiolo et al., 2001; Broughton et al., 
2005; Gronke et al., 2010). We tested the levels of insulin-
like peptides, including Dilp-2, -3, -5, and -7. Among 
them, insulin-like peptide (ILP)-3 and 7 were specifically ele-
vated in fliI3/14 mutants (Fig. 2D). Although fliI3/14 mutant flies 
had high insulin levels, these mutant flies remained hyper-
glycemic, which suggested that fliI3/14 mutants might be 
insulin resistant. Impaired insulin signaling leads to activation 
of 4E-BP (Puig et al., 2003; Teleman et al., 2005). 4E-BP 
levels were higher in fliI3/14 mutants (Fig. 2E), indicating re-
duced insulin sensitivity, despite higher insulin production. 
We also noticed the integrated stress response, which is 
stimulated by endoplasmic-reticulum stress, viral infection, 
amino acid starvation, and other triggers, and converges on 
phosphorylation of the regulatory initiation factor eIF2α at 
serine 51 (Ron, 2002; Ryoo and Vasudevan, 2017; Taniuchi 
et al., 2016). As shown in Figs. 2F and 2G, phosphorylation 
of eIF2α increased in fliI3/14 mutant flies. As FliI has a role in 
actin cytoskeletal activity, as expected, the level of alpha 
tubulin was reduced in fliI3/14 mutants (Figs. 2F and 2G). 
These results suggested that fliI may be a novel regulator 
involved in metabolic disorders. 
 
FliI mutants manifest starvation resistance 
To assess the metabolic roles of fliI, we examined the ability 
of mutants to survive long periods of complete starvation. 
Seven-day-old female flies were reared on a starvation
 
 
 
A                          B                          C 
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Fig. 2. FliI mutants manifest the features of metabolic disorders. (A–C) Hemolymph glucose (A) and trehalose (B) levels in w1118 and fliI3/14 
mutant flies. The relative trehalose and glucose levels slightly but significantly increased in fliI3/14 mutant flies relative to those in w1118 
flies (C). (D, E) Expression levels of indicated gene in w1118 and fliI3/14 mutant flies. (F, G) A representative Western blot of whole-fly ex-
tracts from w1118 and fliI3/14 mutants (F). eIF2α phosphorylation increased in fliI3/14 mutant flies compared to the w1118 strain. The amount 
of α-tub was lower in fliI3/14 mutant flies. (G) Comparison of the normalized anti-phospho-eIF2α band intensity between w1118 flies and 
fliI3/14 mutants. The data are presented as mean ± SE from four independent experiments; *P < 0.05, **P < 0.01, and ***P < 0.001. 
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medium (1% agar in PBS), and the number of surviving flies 
was recorded every 12 h. Under the starvation conditions, 
fliI3/14 mutant flies survived longer than w1118 flies did (P < 
0.0001, logrank test; Fig. 3A). Starvation resistance is directly 
linked to body fat content and serves as a marker of stored-
fat mobilization (Beller et al., 2010). Next, we quantified 
triglycerides in the starved flies. When adult flies were 
starved for 36 h, triglyceride amounts in control flies gradu-
ally decreased by 75% as compared to the control. In con-
trast, fliI3/14 mutant flies had still stored about 76% lipids by 
36 h of starvation (Fig. 3B), indicating that the stored fat 
served as energy reserves. To test whether increased food 
intake caused the elevated energy stores in fliI3/14 mutant 
flies, we performed a blue-dye feeding assay. In control flies, 
food deprivation for 24 h significantly increased food intake 
as compared to fed control flies, but there was no significant 
difference in food intake between the sated and starved 
fliI3/14 mutant flies (Figs. 3C and 3D). To determine whether 
the flight defect has an influence on food intake, we meas-
ured food intake in w1118 flies with clipped wings. As pre-
sented in Supplementary Fig. S2B, the flight defect did not 
change the starvation-induced food intake. Altogether, the-
se results indicated that fliI is crucial for energy homeostasis. 
 
Drosophila fliI suppresses desaturase 1 expression, which 
contributes to lipid storage 
Stearoyl-CoA desaturases (SCDs) are key enzymes in fatty 
acid biogenesis. They catalyze desaturation of saturated 
long-chain fatty acids, preferring palmitoyl-CoA and stearoyl-
CoA as substrates and converting them to palmitoleoyl-CoA 
and oleoyl-CoA, respectively. The resulting monounsaturat-
ed fatty acids, palmitoleoyl-CoA and oleoyl-CoA, are major 
components of triacylglycerol, cholesterol esters, and phos-
pholipids (Enoch et al., 1976; Sampath and Ntambi, 2011). 
In addition, SCDs contribute to anomalous lipid metabolism 
and the progression of obesity (Hulver et al., 2005; Jiang et 
al., 2005). Given that FLII is involved in the expression of 
SCD1 in mammalian cells (Wu et al., 2013) , we determined
 
 
 
A                                        B 
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Fig. 3. FliI mutants are resistant to starvation. (A) Seven-day-old female w1118 flies (controls) and fliI3/14 mutants were subjected to com-
plete starvation, and the numbers of surviving flies were determined at 12 h intervals. The results are presented as a percentage of the 
total population (n = 8, P < 0.0001, 20 flies in each vial). (B) Quantification of triglycerides in starved flies at the indicated time points. 
Although the amounts of triglycerides in w1118 flies decreased by 75% after 36 h of starvation, fliI3/14 mutant flies kept 76% of their 
triglycerides after 36 h of starvation (n = 4, 20 flies in each vial). The statistical analysis was performed between w1118 and fliI3/14 flies at 
each time point after starvation. (C, D) Fasting-induced feeding was less active in fliI3/14 mutants. (C) Blue dye levels were found to be 
elevated in the abdomen of control flies fasted for 24 h as compared to fed controls (w1118 flies). The blue dye was not detected in either 
fasted or fed fliI3/14 mutants (n = 4). (D) Quantitation of the blue dye revealed a significant increase in food consumption in starved con-
trol flies. Data are presented as mean ± SE from four independent experiments; *P < 0.05, **P < 0.01, and ***P < 0.001.
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Fig. 4. Drosophila fliI inhibits lipid storage by suppressing mRNA expression of desaturase 1. (A) Quantitative RT-PCR analysis of desat1 in 
the intestine (left) and fat body (right) from 7-day-old dissected adults. mRNA expression of desat1 was higher in fliI3/14 mutants relative 
to w1118 flies (controls). (B) The mRNA expression of desat1 gradually increased in w1118 flies (control) and fliI3/14 mutants. The transcript 
levels of desat1 at the indicated time points were significantly higher in fliI3/14 mutants than in w1118 flies. (C) For 10 days of RU486 sup-
plementation, the levels of triglycerides in group “P{Switch1}106>fliI, +RU486” significantly decreased relative to the RU486 control 
(P{Switch1}106>fliI, no RU486). (D) Quantitative RT-PCR analysis of desat1 expression (normalized to Rp49 mRNA levels) in whole-body 
extracts of flies reared under conditions identical to those in (C). The overexpression of fliI under the influence of RU486 supplementa-
tion suppressed the mRNA expression of desat1. (E) The analysis of mRNA expression in empty-vector–transfected cells or in FliI-
expressing 3T3-L1 cells. The overexpression of FliI-downregulated transcripts of murine stearoyl-CoA desaturase genes, such as SCD1, 
SCD2, and SCD4. (F) Overexpression of fliI (Act5CGS>fliI, +RU486) significantly increased the sensitivity to starvation as compared to 
RU486 control (Act5CGS>fliI, no RU486) according to the logrank test (P < 0.0001). The number of surviving flies was recorded at 12 h 
intervals. (G) Although the knockdown of fliI under the influence of RU486 supplementation increased the level of triglycerides 
(P{Switch1}106>fliI-IR), the knockdown of desat1 via RU486 supplementation reduced the concentration of triglycerides 
(P{Switch1}106>desat1-IR). The decreased level of triglycerides in the desat1 knockdown flies was significantly reversed by the knock-
down of fliI (P{Switch1}106>fliI-IR, desat1-IR). The amount of triglycerides was normalized to that of group “−RU486” (no supplementa-
tion) for each genotype. Data are presented as mean ± SE from at least three independent experiments. The P values were determined 
by Student’s t test; *P < 0.05, **P < 0.01, and ***P < 0.001. 
 
 
 
whether they are the major cause of the obesity-like pheno-
type in fliI mutants. As expected, we observed increased 
mRNA expression of desat1, a Drosophila homolog of SCD, 
in the intestine and fat body of 7-day-old fliI3/14 mutants (Fig. 
4A). The mRNA expression of desat1 in the whole body of 
fliI3/14 mutants gradually increased fourfold by 7 days after 
hatching in comparison with 0-day-old control flies (w1118; 
Fig. 4B); this result was reminiscent of the progressive in-
crease in triglyceride content of fliI3/14 mutants (Supplemen-
tary Fig. S1). To verify whether the expression of desat1 is 
associated with that of fliI, we generated a fliI transgenic 
strain. We used the inducible gene switch P{Switch1}106 
driver, which can be activated by the addition of mifepris-
tone (i.e., RU486) to the diet (Roman et al., 2001). The 
P{Switch1}106 driver induced fliI expression only in the adult 
fat body. To rule out the possibility that RU486 treatment 
alone affects triglyceride levels, we quantified triglycerides in 
P{Switch1}106/+ flies. As illustrated in Supplementary Fig. S3, 
RU486 alone did not significantly change the concentrations 
of triglycerides. After the flies (P{Switch1}106>fliI) were 
reared for 10 days in the presence or absence of RU486, we 
quantified triglycerides. The levels of triglycerides in the 
whole body decreased in flies overexpressing fliI in the adult 
fat body (P{Switch1}106>fliI, +RU486) relative to control flies 
(P{Switch1}106>fliI, no RU486; Fig. 4C). In agreement with 
this result, when we overexpressed fliI in the fat body by 
means of the P{Switch1}106 driver, the mRNA expression of 
desat1 significantly decreased relative to the level in no-
RU486 controls (Fig. 4D). These results were then validated 
in mammals. In particular, murine fliI expression in 3T3-L1 
preadipocytes significantly reduced the mRNA expression of 
mouse SCD isoforms, such as SCD1, SCD2, and SCD4 (Fig. 
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4E). These findings provided strong evidence that fliI sup-
presses desat1 transcription, which contributes to abnormal 
lipid metabolism. To test whether overexpression of fliI 
changes the survival of starvation-resistant flies, we induced 
the expression of fliI using Act5CGS-Gal4, which drove ex-
pression of fliI in the whole body only when RU486 was 
added to the diet. FliI-overexpressing flies died at a faster 
rate than control flies did (Act5CGS>fliI, no RU486) during 
complete starvation at the indicated time point (Fig. 4F), in 
line with the result in Fig. 3A. 
Next, we tested whether the increase in triglyceride 
amounts in fliI mutants can be reversed by a knockdown of 
desat1. We used the RU486-inducible gene switch driver 
P{Switch1}106-gal4 and downregulated fliI in vivo, in a fliI 
RNA interference (RNAi) strain. The knockdown of fliI trig-
gered upregulation of triglycerides as compared to the 
group without RU486 (Fig. 4G). The Desat1 knockdown in 
the adult fat body decreased the concentrations of triglycer-
ides relative to the no-RU486 controls. By contrast, the 
knockdown of fliI in the adult fat body of desat1-deficient 
flies partially but significantly restored the level of triglycer-
ides (P{Switch1}106>fliI-IR, desat1-IR; Fig. 4G). These results 
suggested that fliI inactivation is responsible for the obesity-
like phenotype because of upregulation of desat1. 
 
DISCUSSION 
 
Here, we demonstrate that Drosophila fliI is a key regulator 
of lipid metabolism. Specifically, fliI suppresses the mRNA 
expression of desat1, eventually causing accumulation of 
triglycerides in the fat body and intestine. As a well-known 
lipogenic enzyme, SCD catalyzes the synthesis of monoun-
saturated fatty acids that are required for the de novo syn-
thesis of membrane phospholipids, triglycerides, and choles-
terol esters (Enoch et al., 1976). Emerging evidence indi-
cates that SCD contributes to fat storage and obesity. The 
absence of SCD lowers fat content and protects against sat-
urated-fat–induced or genetically induced obesity (Cohen et 
al., 2002; Sampath et al., 2007). Because fliI3/14 mutants 
show elevated mRNA levels of desat1, whereas fliI overex-
pression lowers desat1 transcription, we propose that fliI 
downregulates desat1, whereas the latter gene promotes 
the obesity-like phenotype. 
Nevertheless, it is unclear how fliI suppresses the expres-
sion of desat1 and thus downregulates triglycerides. We can 
explain the regulatory mechanism by means of two hypoth-
eses. In mammals, SCD1 expression is regulated by exercise, 
nutrients such as saturated fatty acids and cholesterol, and 
by hormonal factors (Ntambi, 1995; Sinha et al., 2017; Yao 
et al., 2017). Various studies also suggest that the transcrip-
tion of SCD1 is controlled by PPARγ, which controls glucose 
and lipid metabolism as a master regulator of lipogenic-
enzyme expression (Miller and Ntambi, 1996; Singh Ahuja et 
al., 2001; Way et al., 2001; Yao et al., 2017). Our previous 
study revealed that fliI functions as a transcriptional modula-
tor of PPARγ in mammals (Choi et al., 2015). FliI inhibits for-
mation of the complex of PPARγ  with RXRα (retinoid X re-
ceptor α) by competitively interacting with PPARγ. As the 
short carboxy-terminal extensions of the RXRα DNA-binding 
domain (DBD) interact with the DBD of PPARγ  (A et al., 
1997; Chandra et al., 2008), this complex selectively binds to 
peroxisome proliferator response elements. Therefore, the 
expression of adipocyte-specific genes, including aP2, 
C/EBPα (CCAAT/enhancer-binding protein α), adiponectin, 
adipsin, LPL (lipoprotein lipase), FAS (fatty acid synthase), 
and GLUT4 (glucose transporter 4) will increase. On the 
other hand, binding of FliI to the DBD of PPARγ reduces DNA 
occupancy of PPARγ in the promoter of those target genes, 
thereby suppressing adipocyte differentiation (Choi et al., 
2015). Thus, we believe that fliI attenuates PPARγ-induced 
SCD expression although Drosophila does not have an obvi-
ous homolog of PPARγ. We need to further explore how FliI 
and PPARγ interact to promote the expression of SCD in 
mammals. 
Alternatively, the regulation of desat1 expression by fliI 
may depend on the interaction between fliI and glucose-
responsive transcription factor carbohydrate-responsive ele-
ment–binding protein (ChREBP). According to another study 
(Wu et al., 2013), FLII functions as a transcriptional core-
pressor of ChREBP. FLII interacts and colocalizes with 
ChREBP in cancer cells, and FLII overexpression decreases 
transcriptional activity of ChREBP, which results in decreased 
mRNA expression of ChREBP-activated target genes, includ-
ing FAS, SCD1, and thioredoxin-interacting protein (TXNIP). 
In addition, ChREBP coordinately modulates the anabolic 
metabolism regulating gene expression required for the 
conversion of glucose to fatty acids and nucleotides (Yu et al., 
2014). Collectively, these data suggest that the regulation of 
desat1 expression by fliI may be a consequence of some 
upstream event, such as the interaction of fliI and PPARγ or 
ChREBP, not direct transcriptional regulation of desat1 by fliI. 
Recent research indicates that cytoskeletal protein FLII is 
involved in diabetic wound healing (Ruzehaji et al., 2014). 
Consistent with another observation (Kopecki et al., 2009), 
attenuation of FLII expression by a genetic knockdown or by 
a FLII-neutralizing antibody improves wound healing and 
new vessel formation in vivo. In that study, they determined 
the FLII protein expression in nondiabetic and diabetic Flii+/−, 
wild type, and FliiTg/Tg mice, at 0, 7, and 14 days after wound-
ing. Although diabetes increased FLII expression in response 
to wounding, there was no significant change of FLII expres-
sion in unwounded skin in comparison with nondiabetic and 
diabetic groups. Given that obesity is a characteristic feature 
of type II diabetes, the expression of FLII in the murine model 
of type I diabetes evaluated in that study could be somewhat 
different from the pattern of fliI expression seen in our study. 
Besides, we cannot rule out the possibility of species differ-
ences. 
fliI3/14 mutant flies exhibit increased fat storage and are re-
sistant to starvation. In addition, these flies do not consume 
food as much as control flies after 24 h of starvation. Fat 
storage levels are communicated to the central nervous sys-
tem (CNS), which regulates food intake and metabolism (Al-
Anzi et al., 2009). After 24 h of starvation, fliI3/14 mutant flies 
stored approximately 80% of the fat compared to that by 
the fed control flies (Fig. 3B), which is consistent with the 
previous finding that flies with high fat storage levels show a 
decrease in levels of fat store depletion rate compared to 
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that by controls (Al-Anzi et al., 2009). Because fliI3/14 mutant 
flies have sufficient energy and do not feel hungry after 24 h 
of starvation, we assumed that they consumed less amount 
of food compared to controls. However, we need to further 
validate the regulatory mechanisms of the types of appetite 
hormones secreted by the brain of fliI3/14 mutant flies ac-
cording to the energy demand. 
In summary, our results show that Drosophila fliI may serve 
as a key regulator of lipid metabolism, namely, as a suppres-
sor of lipid accumulation; therefore, its function could be 
manipulated to treat metabolic disorders such as obesity and 
diabetes. 
 
Note: Supplementary information is available on the Mole-
cules and Cells website (www.molcells.org). 
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